An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition Aug 16, 2018 | 2018, Archives of Toxicology, Publication - legacy work ‹ Previous Spatio-temporal visualization of the distribution of acetaminophen as well as its metabolites and adducts in mouse livers by MALDI MSI Next › QSAR Development for Plasma Protein Binding: Influence of the Ionization State
